• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PHILIPS/RESPIRONICS, INC. CPAP MACHINE; VENTILATOR, NON-CONTINUOUS (RESPIRATOR)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PHILIPS/RESPIRONICS, INC. CPAP MACHINE; VENTILATOR, NON-CONTINUOUS (RESPIRATOR) Back to Search Results
Model Number DSX520H11C
Patient Problem Aspiration/Inhalation (1725)
Event Date 02/20/2024
Event Type  Injury  
Event Description
I was using philips dreamstation-2 cpap machine as recommended by my doctor.Some white powder like substance spreading / coming out from machine.I stopped using the cpap machine to prevent further negative effect on my health from using the machine.I got this cpap machine from philips after previous machine was recalled.Reference report: #mw5153697.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CPAP MACHINE
Type of Device
VENTILATOR, NON-CONTINUOUS (RESPIRATOR)
Manufacturer (Section D)
PHILIPS/RESPIRONICS, INC.
MDR Report Key19087244
MDR Text Key340125688
Report NumberMW5153696
Device Sequence Number1
Product Code BZD
UDI-Device Identifier00606959062733
UDI-Public(01)00606959062733
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 04/07/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model NumberDSX520H11C
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received04/10/2024
Patient Sequence Number1
Treatment
AZITHROMYCIN-250MG.; CALCIUM.; METFORMIN-500MG.; MONTELUKAST-10MG.; ROSUVASTATIN 20MG.; TRELEGY.; VITAMIN-D.
Patient Outcome(s) Disability; Required Intervention;
Patient Age57 YR
Patient SexMale
Patient Weight67 KG
Patient EthnicityNon Hispanic
Patient RaceAsian
-
-